-
Ryu defeats Henderson in play-off to win back-to-back majors in Evian
-
Argentina football great Rattin dies at 89
-
Spain ex-PM draws criticism with 'xenophobic' remark on French team
-
Argentina great Rattin dies at 89
-
Israel elections to be held on October 27: parliament
-
Bellingham drags England into World Cup semis but Tuchel demands more
-
Zelensky orders new PM in major government reshuffle
-
Pogacar calls for cycling calendar overhaul due to heatwave
-
Van der Poel stays calm in the heat to win Tour de France stage nine
-
Van der Poel wins shortened Tour de France ninth stage
-
Iran declares Hormuz strait closed, US military insists traffic flowing
-
McCullum sacked as England Test coach but retains white-ball role
-
Marc Marquez cruises to Germany MotoGP victory, enters title race
-
Bhatia first woman to score Lord's Test century as India run riot
-
Mladenovic and Guo win Wimbledon women's doubles title
-
'Insane heat': Durbridge calls for earlier Tour de France starts
-
McCullum stands down as England Test cricket coach
-
McCullum stand downs as England Test cricket coach
-
Marc Marquez cruises to Germany MotoGP Grand Prix victory
-
India's Bhatia becomes first woman to score Lord's Test century
-
Ukraine's Zelensky orders government reshuffle, new PM
-
India's Bhatia in sight of becoming first woman to score Lord's Test century
-
Iran, US trade more strikes as fighting escalates
-
Нуша Аубель і Потсдам: довіра втрачена
-
Noosha Aubel and Potsdam: The trust placed in her has been squandered
-
努莎·奧貝爾與波茨坦:先前的信任已蕩然無存
-
US senator and Trump ally Lindsey Graham dies aged 71
-
Evacuees allowed to return home after deadly wildfire in Spain stabilises
-
US-Iran strikes: latest developments
-
Senegal part ways with coach Thiaw after World Cup exit
-
South Korea issues first emergency heatwave warning under new rating system
-
McGregor 'destroyed' in 69 seconds on UFC return from five-year layoff
-
US senator and Trump ally Lindsey Graham dies age 71
-
Hundreds return home as deadly Spain wildfire nears control
-
England, Argentina to renew bitter rivalry in World Cup semi-final
-
Argentina's Scaloni says England World Cup semi 'just a football game'
-
In Sicily, drones at work to predict volcanic eruptions
-
Argentina know how to suffer, says Alvarez after Swiss World Cup test
-
McGregor loses in 69 seconds on UFC return from five-year layoff
-
Iran strikes Gulf neighbours after new US attacks
-
Car crisis takes toll on Germany's young engineers
-
England, Argentina set up World Cup showdown after quarter-final wins
-
Argentina sink 10-man Swiss to set up blockbuster England World Cup semi-final
-
Political violence shadows Bangladesh's new government
-
West Afghanistan female dress-code crackdown hits businesses
-
'We put Norway on the map', says Haaland after World Cup exit
-
Bhutan battles 'existential' population crisis with birth drive
-
Tuchel says 'lucky' England must improve despite reaching World Cup semi-finals
-
Norway coach says ball hit camera cable for crucial England goal
-
'Never in doubt': England fans dare to dream after quarter-final scare
Conflicting US rulings leave fate of abortion pill in doubt
Conflicting rulings by two federal judges have left the future of abortion pills in the United States deeply uncertain, likely placing the divisive issue squarely in the lap of the Supreme Court.
A ruling Friday by federal judge Matthew Kacsmaryk in Texas banned the widely used drug mifepristone (RU 486) nationwide, boosting conservatives' efforts to further restrict abortion rights after the Supreme Court last year allowed states to prohibit them.
The unprecedented rejection of a drug approved in 2000 by the US Food and Drug Administration (FDA) -- and found safe by scientific consensus -- sparked outrage on the political left.
Kacsmaryk, in his ruling, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
His ruling brought an immediate vow from the Biden administration and the drug's maker to appeal the matter in federal court.
Attorney General Merrick Garland said the Justice Department would ask the appeals court to stay the ban by Kacsmaryk, an ultraconservative Donald Trump appointee, until the case is finally resolved.
If the Texas ruling holds, it would complicate matters not just in the states now banning or sharply limiting abortions, but also in those where the procedure remains legal.
- Widely used -
Mifepristone has been used as part of a two-drug regimen by 5.6 million women since 2000.
But adding to the uncertainty and increasing the odds the matter ends up before the Supreme Court was a contradictory ruling from a Washington state judge that came just hours after Kacsmaryk's.
District Judge Thomas Rice, a Barack Obama appointee, ruled in a separate case -- brought by several states where abortion is legal -- that mifepristone is "safe and legal" and that the FDA must preserve access to it in more than a dozen states.
For now the drug remains legal, Alexis McGill Johnson, the head of Planned Parenthood, one of the largest pro-abortion groups in the country, said Friday.
Several abortion clinics also said Friday that they would continue using mifepristone until ordered not to by the FDA, US media reported.
Kacsmaryk paused the effect of his ruling for a week, allowing time for the administration and drugmaker Danco Laboratories to file before the US Fifth Circuit Court of Appeals in Louisiana, which hears cases from Texas.
The Justice Department is still reviewing Rice's ruling, Garland said in a statement.
- 'Remains safe' -
Given the sharply conflicting court rulings, the Justice Department might opt to take the case directly to the Supreme Court and not wait for the Fifth Circuit to act.
The high court could decide to take up the case on an emergency basis, which would require making room in an already crowded agenda at the end of the current term.
In that case, the court -- with six conservative justices outnumbering the three liberals -- could hear the case within days, or weeks, but sometime before the current session ends on June 30.
Chief Justice John Roberts, a conservative, is deeply protective of the image of the institution, and he might be expected to vote with the three liberals in favor of mifepristone. The additional vote of one other conservative could provide a majority for the drug.
The court's ruling last June to overturn the longstanding Roe v. Wade decision protecting abortion rights shifted considerable attention to medication abortions.
Most of them involve mifepristone in a two-drug regimen. A patient first takes a mifepristone pill to end the pregnancy, then a day later takes the drug misoprostol to induce contractions that expel the embryo or fetus.
Misoprostol can be used on its own to cause abortions, but the two-step procedure is considered more effective and can be more painful.
More than half of abortions in the US are done with medication.
Kacsmaryk, in his ruling, said the two-drug regimen had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective.
Michigan Governor Gretchen Whitmer, a Democrat, tweeted:
"Despite this ruling, I want to be clear: abortion, including medication abortion, remains safe and legal in the state of Michigan."
Women's March, which has been organizing organizing major women's rights demonstrations in recent years, called for a nationwide rally defending abortion rights for April 15.
A.Clark--AT